Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

NCT03233204

Conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +85 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 113 locations

View Trial Details

Completed

Lymph Node Dissection Before or After Cystectomy

NCT05939856

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Department of Urology, University Hospital, Jagiellonian University Krakow, Poland

View Trial Details

Completed

Dendritic Cell Vaccination for Patients with Solid Tumors

NCT01291420

Conditions: Adenocarcinoma, Adenoma, Astrocytoma, +50 more
Locations: Antwerp University Hospital, Center for Cellular Therapy and Regenerative Medicine Edegem, Antwerp, Belgium

View Trial Details

Completed

Immunological Response of Bladder Cancer Patients Under BCG

NCT04806178

Conditions: Bacillus Calmette-Guerin, Bladder Cancer, Female Urogenital Diseases, +10 more
Locations: Pontifical Catholic University of Campinas Hospital Campinas, São Paulo, Brazil

Hospital das Clínicas Unicamp Campinas, São Paulo, Brazil

View Trial Details

Completed

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

NCT04319757

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
Locations: Northwestern Univeristy Chicago, Illinois, United States

MD Anderson Cancer Center Houston, Texas, United States

Taipei Veteran General Hospital Taipei, Taiwan

View Trial Details

Completed

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

NCT01224665

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Los Angeles County-USC Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Stanford Cancer Institute Palo Alto, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View all 35 locations

View Trial Details

Completed

Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma

NCT03534804

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

View Trial Details

Completed

TIL Therapy for Metastatic Renal Cell Carcinoma

NCT02926053

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Center for Cancer Immune Therapy Dept. of Hematology/oncology Herlev, Denmark

View Trial Details

Completed

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

NCT02462239

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: Juravinski Cancer Centre Hamilton, Ontario, Canada

London Regional Cancer Centre London, Ontario, Canada

Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada

Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions